US Stocks
/
Editas Medicine, Inc. Share Price

Editas Medicine, Inc. Share Price

NASDAQ: EDIT | Micro Cap
$2.87
-$0.04 (-1.54%) Last updated on 08 Aug, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Editas Medicine, Inc. Stock Performance

Open
$3.00
Prev. Close
$2.92
Circuit Range
N/A
Day Range
$2.87 - $3.09
Year Range
$1.66 - $4.53
Volume
1,21,795
Average Traded
$2.93

Editas Medicine, Inc. Share Price Today

As of 10 August 2026, Editas Medicine, Inc.'s share price is $2.87. The stock opened at $3.00, compared to its previous close of $2.92. During today's trading session, Editas Medicine, Inc.'s share price traded between $2.87 and $3.09, with an average price of $2.98. Over the past 52 weeks, the stock has recorded a high of $4.53 and a low of $1.66. In terms of performance, Editas Medicine, Inc.'s share price has risen by 30.16% over the last six months and is up 12.11% on a year-on-year basis.

Editas Medicine, Inc. Share Price Chart

$2.87$3.09
L
Show Current Price
H

Editas Medicine, Inc. Stock Fundamentals & Key Indicators

Market Cap
$254.70M
PE Ratio (TTM)
-1.59
Dividend Yield
N/A
EPS (TTM)
$-1.80
Revenue (TTM)
$40.52M
Return On Equity (TTM)
-586.56%
Profit Margin
-395.01%
Debt to Equity
1.69
Quarterly Earnings Growth YoY
59.58%

Editas Medicine, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsMar 2024Jun 2024Sep 2024Mar 2025Jun 2025Sep 2025
RevenueN/AN/AN/AN/AN/AN/A
Net Profit-$61.95M-$67.61M-$62.14M-$76.09M-$53.23M-$25.12M
Net Profit MarginN/AN/AN/AN/AN/AN/A
Income ChangeN/A-9.13%8.08%-22.44%30.03%52.82%

Editas Medicine, Inc. Annual Profit & Loss

All figures in USD

Particulars20212022202320242025
RevenueN/AN/AN/AN/AN/A
Net Profit-$192.50M-$220.43M-$153.22M-$237.09M-$160.06M
Net Profit MarginN/AN/AN/AN/AN/A
Income ChangeN/A-14.51%30.49%-54.74%32.49%

About Editas Medicine, Inc.

Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. The company develops a proprietary gene editing platform based on CRISPR technology. It has a research collaboration with Juno Therapeutics, Inc. to develop alpha-beta T-cell experimental medicines for the treatment of solid and liquid tumors. The company was formerly known as Gengine, Inc. and changed its name to Editas Medicine, Inc. in November 2013. Editas Medicine, Inc. was incorporated in 2013 and is based in Cambridge, Massachusetts.

Editas Medicine, Inc. Historical Returns

MonthOpenCloseChange %
Aug 2026
$2.58
$2.87
+11.67%
Jul 2026
$3.33
$2.57
-20.56%
Jun 2026
$3.33
$3.23
-6.37%
May 2026
$2.98
$3.46
+15.17%
Apr 2026
$2.61
$3.00
+21.21%
Mar 2026
$2.10
$2.48
+12.24%
Feb 2026
$1.98
$2.21
+11.36%
Jan 2026
$2.07
$1.98
-3.65%
Dec 2025
$2.36
$2.06
-14.37%
Nov 2025
$3.02
$2.40
-21.82%
Oct 2025
$3.52
$3.07
-11.53%
Sep 2025
$2.53
$3.47
+35.55%

EDIT Share Price FAQs

What is Editas Medicine, Inc. share price today?

chevron-up
Editas Medicine, Inc. share price today is $2.87 as on August 8, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Editas Medicine, Inc. stock?

chevron-up
The 52 week high of Editas Medicine, Inc. stock is $4.53, while the 52 week low is $1.66 as of 8 Aug '26.

What is EDIT's market capitalisation today?

chevron-up
EDIT market capitalisation is $254.70M as of August 10, 2026, at 2:54 pm IST.

What is EDIT's net income for the last quarter?

chevron-up
EDIT's net income for the last quarter is -0.03B USD.

What is the 5 year returns of EDIT?

chevron-up
The 5 year returns of EDIT is -95.49% as on 8 Aug '26.

What is the high & low stock price of EDIT today?

chevron-up
EDIT stock price hit a high of $3.09 and low of $2.87 as of 8 Aug '26.

Can I buy EDIT shares in India?

chevron-up
Yes. You can buy EDIT in India by opening an international trading account.